📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

First data of a quabodepistat containing novel regimen for drug-susceptible tuberculosis. (2024)

First Author: Naidoo K

Attributed to: Addressing challenges in scaling up TB and HIV treatment integration in public health settings in South Africa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(24)00653-4

PubMed Identifier: 39612927

Publication URI: http://europepmc.org/abstract/MED/39612927

Type: Journal Article/Review

Parent Publication: The Lancet. Infectious diseases

ISSN: 1473-3099